Chang Serena Su Ying, Nagarajan Nandhakumar, Tan Joanne Mui Ching
Department of Paediatric Medicine, KK Women's and Children's Hospital, Singapore
Department of Paediatric Medicine, KK Women's and Children's Hospital, Singapore.
BMJ Case Rep. 2021 Mar 23;14(3):e239651. doi: 10.1136/bcr-2020-239651.
A 7-month-old female infant presented with failure to thrive. She was breastfed till 3 months of age, thereafter switched to soy-based milk formula. There was no history to suggest excess energy losses, recurrent infections or chronic diarrhoea. Three months after switching to exclusive soy-based milk formula, parents noticed significant enlargement of both breasts. Clinical examination was unremarkable except for enlargement of both breasts. None of the other secondary sexual characteristics were present. Initial blood investigations showed hyponatraemic hypokalaemic hypochloraemic metabolic alkalosis, which corrected after 2 days with intravenous hydration. The patient subsequently maintained normal electrolyte balance with recommended intake of cow's milk-based standard formula milk.Further exploration of her soy-based milk revealed that it was low in sodium and calories, unsuitable for children. This was not a standard and approved infant soy-based formula milk. She achieved excellent weight gain and reduction of breast size on cessation of soy-based milk formula.
一名7个月大的女婴出现生长发育迟缓。她一直母乳喂养至3个月大,之后改用大豆基婴儿配方奶粉。没有病史提示存在能量过度丢失、反复感染或慢性腹泻。改用纯大豆基婴儿配方奶粉3个月后,父母注意到她的双侧乳房明显增大。除双侧乳房增大外,临床检查无异常。未出现其他第二性征。初步血液检查显示低钠、低钾、低氯性代谢性碱中毒,经静脉补液2天后得到纠正。随后,患者通过摄入推荐的基于牛奶的标准配方奶粉维持了正常的电解质平衡。进一步检查发现,她所食用的大豆基奶粉钠和热量含量低,不适合儿童。这不是标准的、经批准的婴儿大豆基配方奶粉。停用大豆基配方奶粉后,她体重增长良好,乳房尺寸减小。